Market Trends of Indonesia Diabetes Care Devices Industry
Management Devices Hold Highest Market Share in Indonesia Diabetes Care Devices Market
Patients with Type 1 diabetes (T1D) must maintain healthy lifestyle conditions, which are impacted by t person's personality traits, social interactions, socioeconomic circumstances, and environmental living factors. TContinuousglucose monitoring (CGM) with multiple daily injections (MDI) has shown a reduction in nonsevere and severe hypoglycemia in people with T1D prone to this adverse event.
Insulin pump therapy has long been established as a reliable method for administering insulin to individuals with type 1 diabetes (T1DM). These pumps have been proven to be an effective treatment option for T1DM patients of all ages, allowing for insulin delivery that closely mimics the body's natural production in cases where the pancreas is unable to produce insulin. Some pump models even come equipped with remote controls, giving parents of young children the ability to remotely suspend or administer insulin while their child is playing or eating.
Insulin infusion pumps have been shown to minimize drastic fluctuations in blood glucose levels, cause less discomfort, and provide more precise insulin delivery compared to traditional injections. These advantages are expected to drive growth in the market for insulin pumps.
The market is further bolstered by the increasing number of vendors, ongoing research and development efforts, advancements in technology, and the widespread availability of advanced products worldwide. Additionally, favorable reimbursement policies in developed countries and growing awareness programs in developing nations are contributing to the market's expansion.
Increasing Type -1 Diabetes Population in Indonesia
In terms of the number of people with diabetes, Indonesia ranks seventh in the world. In Indonesia, people's health is primarily covered by national government insurance. Government insurance covers medical requirements such as consultation, hospitalization, insulin, and needles through designated clinics, hospitals, and licensed pharmacies. However, due to a lack of knowledge and information on Type 1 diabetes, a misunderstanding occurred, resulting in insulin access limits.
The amount of insulin made available through government insurance was limited. For example, a child with Type 1 diabetes who is supposed to receive eight insulin pens per month was only given five insulin pens per month, requiring the parents to purchase the remaining three pens at their own expense. They could not meet their child's insulin needs if they did not have the money. One of the world's most populous nations,
Indonesia has about 11 million diabetics, or 6.3% of the population. As a result, Indonesia ranks among the nations with the highest proportion of people with diabetes. Diabetes is one of Indonesia's leading causes of death, according to WHO data from 2016. Diabetes management strategies in Indonesia include pharmacological treatment, education, physical activity, and dietary management.
The COVID-19 pandemic and the related social restriction policy implemented by the Indonesian government to reduce transmissions have affected diabetes management and increased diabetes-related complications in a nation with a large diabetes population.
As a result, the diabetes care devices market in Indonesia is predicted to expand gradually in the coming years.
